Nu-Life Solutions is the global provider of Nu-V3, our non-invasive, non-pharmaceutical neuromodulation technology for the mitigation or relief from pain, anxiety, depression, and sleeplessness, which is miniaturized, wearable and allows for almost any everyday activity throughout treatment. Nu-V3 is patented in the U.S. Japan, Europe and Latin America and Canada, proven safe and effective by IRB approved clinical trial and within months of regulatory clearance and market launch. Nu-Life is now prepared to explore opportunities for partnership and collaboration as we prepare to launch Nu-V3 in the 4^th quarter of 2025.